T50.A12 Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm

Name of the Condition

• Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm

Summary

This condition describes intentional self-harm resulting from exposure to pertussis (whooping cough) vaccine, either alone or in combination with other vaccine components. The clinical presentation and management depend on the nature of the exposure and the patient's response to the vaccine.

Causes

Intentional self-harm may occur due to deliberate administration of the vaccine to oneself, often as part of a suicidal or self-injurious act. This can involve self-injection or ingestion of the vaccine product.

Risk Factors

• History of mental health conditions (e.g., depression, suicidal ideation)
• Prior self-harm behaviors or attempts
• Access to vaccine products outside of clinical settings
• Intentional misuse of medical supplies or medications

Symptoms

• Local reactions: swelling, redness, or pain at the injection site
• Systemic reactions: fever, chills, malaise, or allergic responses (e.g., rash)
• Severe reactions: high fever, breathing difficulties, seizures, or anaphylaxis
• Psychological symptoms: distress, confusion, or altered mental status

Diagnosis

Diagnosis involves reviewing the patient's history, including details of the exposure, and assessing clinical symptoms. Laboratory tests may be used to evaluate vaccine-related toxicity or allergic reactions. Documentation of intentional self-harm is critical for accurate coding.

Treatment Options

Treatment focuses on managing acute symptoms, such as antihistamines for allergic reactions or supportive care for systemic effects. Psychological evaluation and intervention are essential for addressing the underlying self-harm behavior.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and the timeliness of treatment. Follow-up care includes monitoring for delayed symptoms and addressing mental health needs to prevent recurrence.

Complications

• Severe allergic reactions (e.g., anaphylaxis)
• Neurological complications (e.g., seizures)
• Psychological distress or worsening of mental health conditions
• Long-term physical effects from vaccine-related toxicity

Lifestyle & Prevention

• Secure storage of vaccine products to prevent access
• Mental health support and crisis intervention for at-risk individuals
• Education on safe vaccine handling and disposal
• Regular screening for self-harm risk in clinical settings

When to Seek Professional Help

Seek immediate medical attention if symptoms of severe reaction (e.g., difficulty breathing, seizures) occur after vaccine exposure. Psychological support should be sought for ongoing self-harm concerns.

Tips for Medical Coders

Document the intentional self-harm nature of the exposure clearly. Include details of the vaccine type (pertussis alone or in combination) and the clinical context. Ensure the code T50.A12 is used when the event is classified as intentional self-harm.